RCI
BMY icon

RS Crum Inc’s Bristol-Myers Squibb BMY Stock Holding History

RS Crum Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Hold
6,570
– – 0.07% 77
2026
Q1 		$398K Hold
6,570
– – 0.08% 71
2025
Q4 		$354K Hold
6,570
– – 0.07% 76
2025
Q3 		$296K Hold
6,570
– – 0.07% 81
2025
Q2 		$304K Hold
6,570
– – 0.07% 79
2025
Q1 		$401K Buy
6,570
+58
+0.9% +$3.38K 0.11% 60
2024
Q4 		$368K Hold
6,512
– – 0.09% 65
2024
Q3 		$337K Hold
6,512
– – 0.08% 75
2024
Q2 		$270K Hold
6,512
– – 0.07% 79
2024
Q1 		$353K Sell
6,512
-530
-8% -$27K 0.1% 59
2023
Q4 		$361K Hold
7,042
– – 0.11% 55
2023
Q3 		$409K Buy
+7,042
New +$431K 0.15% 49

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RS Crum Inc's BMY Position: Q2 2026 in Review

RS Crum Inc held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,570 shares worth $379K. The position accounts for 0.07% of the portfolio, ranked #77.

RS Crum Inc first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $409K in Q3 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • RS Crum Inc held 6,570 shares of Bristol-Myers Squibb worth $379K as of Q2 2026.
  • RS Crum Inc left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.07% of RS Crum Inc's portfolio in Q2 2026, its #77 holding.
  • RS Crum Inc first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
  • RS Crum Inc's Bristol-Myers Squibb position peaked at $409K in Q3 2023.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on RS Crum Inc's 13F filing for Q2 2026, filed 10 Aug 2026.